Stay updated on Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial

Sign up to get notified when there's something new on the Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    A site-wide notice about NIH terminology changes appears above the error page, and the footer revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T00:37:25.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-07T00:57:44.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error instead of the study record content. Previous content including locations, institutions, and study details has been removed and replaced by a simple error page with only a Home link.
    Difference
    19%
    Check dated 2026-09-23T00:39:31.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The page's revision label was updated from Revision: v3.6.6 to Revision: v3.7.0, indicating a maintenance/upgrade of the ClinicalTrials.gov interface for this record. The study information and controls remain the same.
    Difference
    0.1%
    Check dated 2026-09-15T23:52:47.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.5 to v3.6.6. This reflects a new version of the page without altering its substantive content.
    Difference
    0.1%
    Check dated 2026-09-01T20:04:29.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The page now displays revision v3.6.5, replacing the previous v3.6.4. This indicates a minor update to the page's release/version metadata without changing the study content.
    Difference
    0.1%
    Check dated 2026-08-11T13:30:58.000Z thumbnail image

Stay in the know with updates to Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab, Ipilimumab, Bicalutamide in HER2- Clinical Trial page.